文献速递消化道肿瘤放疗放疗物理与技术

可吸收不透射线水凝胶在临界可切除及局部晚期胰腺癌图像引导放疗中的评估

Evaluation of a Novel Absorbable Radiopaque Hydrogel in Patients Undergoing Image Guided Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma.
PubMed 文献 · Pract Radiat Oncol · 2020-03-07

本研究评估内镜超声引导下将不透射线水凝胶放置于胰十二指肠沟的可行性与安全性,对象为临界可切除/局部晚期胰腺癌患者。6例可评估患者水凝胶放置均成功,体积及水凝胶泡间距离变化满足等效性假设,仅1例出现3级恶心,无其他不良事件。

要点

  • 内镜超声引导下胰十二指肠沟注射水凝胶在6例可评估患者中均成功放置。
  • 从模拟CT到SBRT后CT,水凝胶体积平均变化-1.0%,泡间距离变化满足等效性。
  • 仅1例出现3级恶心,无其他不良事件,支持后续水凝胶作为间隔物的临床试验。

核心结论

  • 在临界可切除/局部晚期胰腺癌患者中,内镜超声引导下向胰十二指肠沟注射水凝胶标记物具有可行性和安全性。

研究设计与样本

  • 前瞻性评估内镜超声引导下于基准标记放置时向胰十二指肠沟注射水凝胶,随后行模拟CT及33 Gy分5次的大分割立体定向体部放疗(SBRT)。

主要发现

  • 6例可评估患者水凝胶放置均成功。
  • 水凝胶泡间距离中位数和均值平均变化分别为-0.43 mm和-0.35 mm,P < .05。
  • 从模拟CT到SBRT后CT水凝胶体积平均变化-1.0%,P < .05。
  • 1例患者在基准标记/水凝胶放置后出现3级恶心,截至报告时无其他不良事件。

关键数值与推荐

  • 等效性检验以体积平均百分比变化≥20%及泡间表面距离中位数和均值变化≥2 mm为零假设,P < .05拒绝零假设并判定等效。
  • 水凝胶放置成功定义为模拟CT上于胰十二指肠沟识别出水凝胶。

临床怎么用

  • 该技术可为后续将水凝胶作为胰腺肿瘤与剂量限制性放射敏感十二指肠之间的间隔物的临床试验奠定基础。

局限性

  • 原文未报告样本量以外的多中心数据或长期随访结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We assessed the feasibility and safety of placing a radiopaque hydrogel in the pancreaticoduodenal groove via endoscopic ultrasound guidance in patients with borderline resectable/locally advanced pancreatic cancer (BR/LAPC). METHODS AND MATERIALS: Hydrogel injections were done at time of fiducial placement to form blebs in the pancreaticoduodenal groove. Patients subsequently underwent simulation computed tomography (sim-CT) followed by hypofractionated stereotactic body radiotherapy (SBRT; 33 Gy in 5 fractions). Four to 8 weeks after SBRT, patients underwent CT re-evaluation for surgical candidacy and assessment of hydrogel location and size. Hydrogel placement was considered successful if identified in the pancreaticoduodenal groove on sim-CT scan. Stability was evaluated using equivalence testing analyses, with a null hypothesis of the presence of a ≥20% mean percentage change in volume and ≥2 mm change in the median and mean interbleb surface distance with a P value <.05 required to reject the null hypothesis and conclude equivalence. For patients undergoing pancreaticoduodenectomy, hydrogel sites were histologically examined for location and local inflammatory reactions. RESULTS: Hydrogel placement was successful in 6 of the 6 evaluable patients. The average changes in median and mean interbleb distances were -0.43 mm and -0.35 mm, respectively, with P < .05. The average change in volume from sim-CT to post-SBRT CT was -1.0%, with P < .05. One patient experienced grade 3 nausea after fiducial/hydrogel placement, with no other adverse events to date. CONCLUSIONS: These data demonstrate feasibility and safety of injecting a hydrogel marker in the pancreaticoduodenal groove in patients with BR/LAPC and set the stage for a follow-up clinical trial to place hydrogel as a spacer between the pancreatic tumor and dose-limiting, radiosensitive duodenum.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Rao AD, Shin EJ, Meyer J, et al. Evaluation of a Novel Absorbable Radiopaque Hydrogel in Patients Undergoing Image Guided Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma. Pract Radiat Oncol. 2020. PMID: 32151732. doi:10.1016/j.prro.2020.01.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。